Skip to Content

11/22 Tivity Health, Inc. [NASDAP: TVTY]

Federman & Sherwood Announces the Filing of a Securities Class Action Lawsuit against Tivity Health, Inc. Oklahoma City, OK (November 22, 2017) – On November 20, 2017, a securities class action lawsuit was filed in the United States District Court for the Middle District of Tennessee against Tivity Health, Inc. (NASDAQ: TVTY). The complaint alleges violations of federal securities laws, Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5, including allegations of issuing a series of material or false misrepresentations to the market which had the effect of artificially inflating the market price during the Class […]

11/22 Array Biopharma, Inc. [NASDAQ: ARRY]

Federman & Sherwood Announces the Filing of a Securities Class Action Lawsuit against Array Biopharma, Inc. Oklahoma City, OK (November 22, 2017) – On November 20, 2017, a securities class action lawsuit was filed in the United States District Court for the District of Colorado against Array Biopharma, Inc. (NASDAQ: ARRY). The complaint alleges violations of federal securities laws, Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5, including allegations of issuing a series of material or false misrepresentations to the market which had the effect of artificially inflating the market price during the Class Period, […]

11/11 CTI BioPharma Corp. – Settlement Notice

To: All persons and/or entities who purchased or otherwise acquired any shares of the common stock of CTI BioPharma Corp. [CTIC] during the period from March 9, 2015 to February 9, 2016 and were damaged thereby; a settlement has been announced in the securities litigation known as In re CTI BioPharma Corp. Securities Litigation, 2:16-cv-00216-RSL, filed in the United States District Court for the Western District of Washington. For additional information about this settlement, please see the Notice and Proof of Claim (links provided below): Notice of Pendency and Proposed Settlement of Class Action and Settlement Fairness Hearing; Proof of Claim and Release. […]

11/08 General Electric Company [NYSE: GE]

Federman & Sherwood Announces the Filing of a Securities Class Action Lawsuit against General Electric Company Oklahoma City, OK (November 8, 2017) – On November 1, 2017, a securities class action lawsuit was filed in the United States District Court for the Southern District of New York against General Electric Company (NYSE: GE). The complaint alleges violations of federal securities laws, Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5, including allegations of issuing a series of material or false misrepresentations to the market which had the effect of artificially inflating the market price during the […]

11/07 Intercloud Systems, Inc. – Settlement Notice

To: All persons and/or entities who purchased common stock in InterCloud Systems, Inc. [ICLD] during the period from December 3, 2013 through and Including March 27, 2014, and were damaged thereby; a settlement has been announced in the securities litigation known as In re InterCloud Systems, Inc. Securities Litigation, Master Docket No. 3:14-01982-PGS-DEA, in the United States District Court for the District of New Jersey. For additional information about this settlement, please see the Notice and Proof of Claim (links provided below): Notice of Pendency and Proposed Settlement of Class Action and Settlement Fairness Hearing; Proof of Claim and Release. Claim submission deadline […]

10/26 Imperva, Inc. – Settlement Notice

To: All persons and/or entities who purchased or otherwise acquired Imperva, Inc. [NASDAQ: IMPV] securities between May 2, 2013 through April 9, 2014, inclusive, a settlement has been announced in the class action known as Viswanath V. Shankar v. Imperva, Inc., et al. Civil Action No. 4:14-cv-01680-PJH, filed in the United States District Court for the Northern District of California. For additional information about this settlement, please see the Notice and Proof of Claim (links provided below) Notice of Pendency and Proposed Settlement of Class Action Proof of Claim and Release The deadline to file a Proof of Claim and Release is January 22, […]

10/25 Antares Pharma, Inc.

Federman & Sherwood Announces the Filing of a Securities Class Action Lawsuit against Antares Pharma, Inc. Oklahoma City, OK (October 25, 2017) – On October 23, 2017, a securities class action lawsuit was filed in the United States District Court for the District of New Jersey against Antares Pharma, Inc. (NASDAQ: ATRS). The complaint alleges violations of federal securities laws, Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5, including allegations of issuing a series of material or false misrepresentations to the market which had the effect of artificially inflating the market price during the Class […]

10/18 Navient Corporation [NASDAQ: NAVI]

Federman & Sherwood Announces the Filing of a Securities Class Action Lawsuit against Navient Corporation Oklahoma City, OK (October 18, 2017) – On October 16, 2017, a securities class action lawsuit was filed in the United States District Court for the District of New Jersey against Navient Corporation (NASDAQ: NAVI). The complaint alleges violations of federal securities laws, Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5, including allegations of issuing a series of material or false misrepresentations to the market which had the effect of artificially inflating the market price during the Class Period, which […]

let’s connect

Click Here to Complete Federman & Sherwood Fee Agreement.

OKLAHOMA Office

10205 North Pennsylvania Avenue
Oklahoma City, Oklahoma 73120

TEXAS Office

212 W. Spring Valley Road,
Richardson, Texas 75081